YK-11 is a unique compound acting both as a partial androgen receptor agonist and as a myostatin inhibitor, distinguishing it from conventional SARMs. Research has examined YK-11 for its dual mechanism — androgenic receptor pathway activation alongside suppression of the myostatin (GDF-8) pathway that normally limits muscle growth. Preclinical in-vitro research has demonstrated YK-11's capacity to strongly induce follistatin expression and promote muscle cell differentiation. Its combined SARM/myostatin inhibitor profile makes it a unique and highly studied research compound. PeptideBull provides YK-11 at research-grade purity. Not for human or veterinary consumption.
Research Articles
IGF-1 and Muscle Satellite Cells: Fueling Myogenesis Research
Investigate the intricate relationship between IGF-1 and muscle satellite cells, a cornerstone of myogenesis research. D...
Peptide Reconstitution: Bacteriostatic Water Research Guide
Explore the essential guide to peptide reconstitution with bacteriostatic water. Learn proper techniques, storage, and b...
BPC-157 and the Gut Microbiome: Emerging Research
Investigate the intricate relationship between BPC-157 and the gut microbiome. This article delves into emerging researc...